Back to search

Ireland· IE-PA-PA1142/037/001

Stelazine 1mg Film-coated Tablets

A trifluoperazine product containing trifluoperazine, registered in Ireland by Amdipharm Limited. The same ATC class is registered in 5 of our 19 countries.

ATC N05AB06

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedStelazine 1mg Film-coated TabletsATCN05AB06REGISTER NO.IE-PA-PA1142/037/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Trifluoperazine is registered in 5 of 19 countries.

Countries holding a registration under ATC N05AB06 (trifluoperazine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose

Trifluoperazine · ATC N05AB06

5 / 19 countries

  • Finlandprice
  • Ireland
  • Italyprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trifluoperazine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trifluoperazine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • IT Italy$1.02
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Trifluoperazine
Manufacturer
Amdipharm Limited
Country
Ireland (IE)
ATC code
N05AB06
ATC class
Trifluoperazine
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1142/037/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

345 interactions on record for trifluoperazine.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trifluoperazine · interactions on record

345 records

  • 49 severe
  • 287 moderate
  • 9 minor

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trifluoperazine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trifluoperazine products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Cyprus · Stelazine, Trifluoperazine Remedica
  • United Kingdom (Northern Ireland) · Stelazine, Trifluoperazine
  • Greece · Stelazine
  • Italy · Modalina
  • Malta · Trifluoperazine Remedica

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b6a27ed1-380c-4bf7-ac2d-14a77d63cda6
GET /v1/drugs/b6a27ed1-380c-4bf7-ac2d-14a77d63cda6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05AB",
    "N05AB06"
  ],
  "strength": null,
  "pa_number": "PA1142/037/001",
  "substances": [
    "Trifluoperazine"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1977",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about trifluoperazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.